Search - tctmd.com

Displaying 201 - 220 of 382

Sort: Relevancy | Date

Presentation TCT 2017

Lessons from the ABSORB Clinical Program for the Future

Presenter: Gary S. Mintz, Seung-Jung Park, Patrick W. Serruys

October 29, 2017

Presentation TCT 2017

Bioresorbable Scaffolds Are Here to Stay!

Presenter: Antonio Colombo, Stephen G. Ellis, Ron Waksman

October 29, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

Presentation TCT 2017

Flash Debate #3: Should BVS Scaffolds Be Used Today? No - The Evidence Says So!

Presenter: Jun-Jack Cheng, Kenneth Chin, Jack Wei Chieh Tan

October 29, 2017

Presentation TCT 2017

Flash Debate #3: Should BVS Scaffolds Be Used Today? Yes They Are Quite Safe With the Appropriate Implantation Strategy!

Presenter: Jun-Jack Cheng, Kenneth Chin, Teguh Santoso

October 29, 2017

Presentation TCT 2017

Current Updates on BVS: Asia-Pacific and Worldwide

Presenter: Jun-Jack Cheng, Kenneth Chin, Chiung Jen Wu

October 29, 2017

Presentation TCT 2017

Flash Debate #2: Is Shortening D2B Time Still Important in Primary PCI? No - Other Quality Metrics Are More Important!

Presenter: Jun-Jack Cheng, Kenneth Chin, Sreenivas Arramraju Kumar

October 29, 2017

Presentation TCT 2017

Flash Debate #2: Is Shortening D2B Time Still Important in Primary PCI? Yes- D2B Time Is an Index of Quality Care for STEMI!

Presenter: Jun-Jack Cheng, Kenneth Chin, Wei-Chun Huang

October 29, 2017

Presentation TCT 2017

PCI for STEMI With Cardiogenic Shock: Essential Management Strategies and Devices

Presenter: Jun-Jack Cheng, Kenneth Chin, Hsiu-Yu Fang

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

Shelley Wood

September 30, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Daily News

No More Absorb BVS: Abbott Puts a Stop to Sales

Caitlin E. Cox

September 08, 2017

News Conference News ESC 2017

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

Shelley Wood

August 30, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2017

Shelley Wood

July 31, 2017

News Daily News

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

Shelley Wood

July 21, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

News Daily News

ABSORB II Substudy Digs Into Long-term Arterial Remodeling Following BRS, DES Implantation

Yael L. Maxwell

June 29, 2017

Advertisement

Lessons from the ABSORB Clinical Program for the Future

Bioresorbable Scaffolds Are Here to Stay!

TCTMD’s Top 10 Most Popular Stories for October 2017

Flash Debate #3: Should BVS Scaffolds Be Used Today? No - The Evidence Says So!

Flash Debate #3: Should BVS Scaffolds Be Used Today? Yes They Are Quite Safe With the Appropriate Implantation Strategy!

Current Updates on BVS: Asia-Pacific and Worldwide

Flash Debate #2: Is Shortening D2B Time Still Important in Primary PCI? No - Other Quality Metrics Are More Important!

Flash Debate #2: Is Shortening D2B Time Still Important in Primary PCI? Yes- D2B Time Is an Index of Quality Care for STEMI!

PCI for STEMI With Cardiogenic Shock: Essential Management Strategies and Devices

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

TCTMD’s Top 10 Most Popular Stories for September 2017

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

No More Absorb BVS: Abbott Puts a Stop to Sales

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

TCTMD’s Top 10 Most Popular Stories for July 2017

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

TCTMD’s Top 10 Most Popular Stories for June 2017

ABSORB II Substudy Digs Into Long-term Arterial Remodeling Following BRS, DES Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content